If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBloomsbury Regulatory News (BMY)

Share Price Information for Bloomsbury (BMY)

Share Price is delayed by 15 minutes
Get Live Data
641.00    -2.00 (-0.31%)
Bid:
640.00
Ask:
642.00
Spread: 2.00 (0.312%)
Market Cap: £518.20m
BMY Live PriceLast checked at - London Stock Exchange

Intraday Bloomsbury Share Chart

Trading Statement

13 Jan 2011 07:00

RNS Number : 3815Z
Bloomsbury Publishing PLC
13 January 2011
 



 

 

 

 

 

13 January 2011

 

 

 

Bloomsbury Publishing Plc

("Bloomsbury" or "the Group")

Trading Statement

 

 

Bloomsbury Publishing today announces its trading update for the twelve month period ending 31 December 2010 and reports that 2010 trading was in line with management's expectations.

2010 book sales were excellent, driven by revenues from a broad range of titles across our UK, US and German businesses. Sales in the final quarter proved resilient despite the adverse weather conditions. In the UK, The Man Booker Prize winner, The Finkler Question by Howard Jacobson, Operation Mincemeat by Ben Macintyre, the film tie-in edition of Eat, Pray, Love by Elizabeth Gilbert and The Flavour Thesaurus by Niki Segnit were amongst our top selling new titles. Books published in prior years continued to be in demand, led by River Cottage Everyday by Hugh Fearnley-Whittingstall and the seven Harry Potter books, which sold well on the back of the film Harry Potter and the Deathly Hallows Part 1 and the release of the series with new jacket designs.

In the US, we also published The Finkler Question and this continued to be one of our top sellers in the run-up to Christmas and reached the New York Times bestseller list. In addition, Entice by Carrie Jones and Deadly Spin by Wendell Potter were strong sellers. In Germany, the second half of the year had a stronger publishing programme. Eat, Pray, Love performed well and Berthold Beitz: Die Biographie by Joachim Käppner was also a bestseller.

E-book revenues gathered momentum in 2010 and in some cases made up a sizable percentage of sales by value of some of our bestsellers. With the increase in the number of e-readers and other platforms sold into the market, we expect e-book revenue growth to continue. 

We have received a positive response to database projects and management contract proposals and are in discussion with third parties about these. Our strategic investment in academic and professional publishing is progressing well with Public Library Online, Bloomsbury Academic, Methuen Drama, the Arden Shakespeare and the online Berg Fashion Library, which with the The Oxford University Press Encyclopedia of World Dress and Fashion, was awarded the 2011 Dartmouth Medal for its extensive and outstanding multidisciplinary coverage of dress, fashion and its impact on society. Bloomsbury Qatar Foundation Journals was launched by Qatar Foundation in November where we are supplying publishing services. In other specialist areas A&C Black showed solid sales particularly with Alexander McQueen: Genius of a Generation.

Period-end cash for the Group is likely to be in the region of £34.2m.

The results for the twelve month period ended 31st December 2010 will be announced on 28th February 2011. As a reminder the Company's year-end is moving to the end of February and, accordingly, we shall also announce results for the fourteen month period to 28 February 2011 in May.

-ends-

Enquiries:

Pelham Bell Pottinger - Dan de Belder / Rosanne Perry 020 7861 3232

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTKMGMMNZZGMZM
Date   Source Headline
27th Jun 20087:21 amRNSAGM Statement
12th Jun 20083:51 pmRNSHolding(s) in Company
11th Jun 200811:01 amRNSDirector/PDMR Shareholding
29th May 20082:52 pmRNSDirector/PDMR Shareholding
16th May 20087:00 amRNSInterim Management Statement
14th May 20089:06 amRNSDirector/PDMR Shareholding
25th Apr 20084:35 pmRNSDirector/PDMR Shareholding
24th Apr 20083:12 pmRNSDirector/PDMR Shareholding
10th Apr 20083:31 pmRNSHolding(s) in Company
1st Apr 20087:01 amRNSFinal Results
27th Mar 200810:40 amRNSDirector/PDMR Shareholding
11th Mar 200811:53 amRNSHolding(s) in Company
28th Feb 200812:06 pmRNSDirector/PDMR Shareholding
31st Jan 200810:22 amRNSDirector/PDMR Shareholding
22nd Jan 200811:20 amRNSAnnual Information Update
15th Jan 20087:01 amRNSTrading Statement
4th Jan 20085:06 pmRNSDealing by EBT
21st Dec 200711:30 amRNSDirector/PDMR Shareholding
19th Dec 200710:46 amRNSDirector/PDMR Shareholding
23rd Nov 20073:21 pmRNSDirector/PDMR Shareholding
19th Nov 20074:29 pmRNSBlocklisting Interim Review
11th Oct 200712:39 pmRNSHolding(s) in Company
9th Oct 20073:24 pmRNSHolding(s) in Company
8th Oct 20079:21 amRNSDirector/PDMR Shareholding
26th Sep 20074:43 pmRNSDirector appointment
26th Sep 20078:37 amRNSDirector/PDMR Shareholding
18th Sep 20077:02 amRNSInterim Results
10th Sep 20077:02 amRNSPublishing partnership
5th Sep 20072:08 pmRNSNotice of Results
5th Sep 20077:02 amRNSDirectorate Change
20th Aug 200711:50 amRNSHolding(s) in Company
13th Aug 20079:08 amRNSHolding(s) in Company
7th Aug 20079:58 amRNSHolding(s) in Company
3rd Aug 20072:30 pmRNSFinance Database Partnership
30th Jul 20077:01 amRNSDeathly Hallows
25th Jul 20075:14 pmRNSHolding(s) in Company
23rd Jul 20075:15 pmRNSFirst 24 hour sales
5th Jul 20075:51 pmRNSHolding(s) in Company
2nd Jul 20079:34 amRNSTotal Voting Rights
28th Jun 20071:28 pmRNSResult of AGM
28th Jun 20077:02 amRNSAGM Statement
18th Jun 20079:14 amRNSHolding(s) in Company
4th Jun 20075:08 pmRNSDirector/PDMR Shareholding
29th May 200710:39 amRNSNotice of AGM
18th May 200710:56 amRNSBlocklisting Interim Review
10th May 20075:26 pmRNSDirector/PDMR Shareholding
4th Apr 200711:52 amRNSDirector/PDMR Shareholding
3rd Apr 20077:02 amRNSFinal Results
30th Mar 200710:58 amRNSHolding(s) in Company
29th Mar 20078:54 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.